Examples of using Activelle in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Activelle contains lactose.
BEFORE YOU TAKE ACTIVELLE.
Activelle contains lactose monohydrate.
You may start treatment with Activelle on any convenient day.
Activelle is not indicated during pregnancy.
Pregnancy and breast-feeding Do not take Activelle if you are pregnant or breast-feeding.
What Activelle contains• The active substances are estradiol and norethisterone acetate.
Adding a progestagen, such as in Activelle, greatly reduces this increased risk.
Rarely, these conditions may come back or get worse during treatment with Activelle.
Lactation Activelle is not indicated during lactation.
OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF ACTIVELLE AND ASSOCIATED NAMES SEE ANNEX I.
What Activelle looks like and contents of the pack The film-coated tablets are white, round with a diameter of 6 mm.
Before you start treatment and regularly during treatment,your doctor will evaluate whether Activelle is a suitable treatment for you.
Activelle and associated names(see Annex I) 0.5 mg/ 0.1 mg film-coated tablets See Annex I- To be completed nationally.
This systematic review therefore supports that acontinuous combined low dose regimen, as in Activelle 0,5mg/ 0,1mg, would provide sufficient endometrial protection.
Activelle 1 mg/ 0.5 mg tablets, should be considered if the response after three months is insufficient for satisfactory symptom relief.
Taking into account the points above,the some CHMP were of the opinion that endometrial safety of Activelle 0.5 mg/ 0.1 mg could not be supported by the KLIM/ PD/ 7/ USA trial.
In the already licensed dose of Activelle, the ratio between NETA and E2 is 1:2, while this ratio is 1:5 in the new strength of Activelle.
In addition to the above mentioned adverse drug reactions, those presented below have been spontaneously reported,and are by an overall judgement considered possibly related to Activelle 1 mg/0.5 mg treatment.
Activelle belongs to a group of hormone replacement therapy(HRT) medicines, called continuous combined HRT which are taken every day without interruptions.
The majority of the CHMP considered that the applicant/ MAH had adequately justified why an endometrialbiopsy study on the exact dose was not performed, unlike with Activelle 0,5mg/ 0,1mg.
Activelle 0.5 mg/ 0.1 mg is a continuous combined hormone replacement therapy(HRT) product containing 0.5 mg estradiol(E2) and 0.1 mg norethisterone acetate NETA.
During their June 2008 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that thebenefit/ risk ratio is favourable for Activelle and associated names, that the objections raised by France and Germany should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
Activelle 0.5 mg/ 0.1 mg is a continuous combined HRT that contains the half dose of estradiol(E2) and the fifth of the dose of norethisterone acetate(NETA) that in the known fixed combination Activelle E2 1 mg/ NETA 0.5 mg.
On the basis of all these data,the majority of the CHMP was of the opinion that Activelle 0.5 mg estradiol/ 0.1 mg NETA is safe in terms of endometrial hyperplasia and neoplasia risk and that it offers a needed low-dose hormone replacement alternative with a positive benefit-risk.
This refers to endometrial safety of Activelle 0.5 mg/ 0.1 mg, which had been insufficiently demonstrated according to the CHMP guideline for HRT products(EMEA/ CHMP/ 021/ 97 rev 1) and this was considered to be of serious public health concern.
Summary of CHMP' s Opinion The CHMPnoted that the applicant had provided the following arguments to support the endometrial safety of Activelle 0.5 mg/ 0.1 mg: a. the proliferative effect of unopposed oestrogens on the endometrium is dose-dependant, b. this proliferative effect of unopposed oestrogens is time-dependant, especially for high oestrogen doses, c. continuous combined therapy over long duration is more protective that sequential therapy in the prevention of endometrial hyperplasia or carcinoma.
Austria- Noviana 0,5mg/0,1mg filmtabletten Belgium- Activelle minor comprimés pelliculés Bulgaria- Noviana™ филмирани таблетки Czech Republic- Noviana potahované tablety Denmark- Activelle low filmovertrukne tabletter Estonia- Activelle low 0,5 mg/0,1 mg õhukese polümeerikattega tablett Finland- Activelle 0,5 mg/0,1 mg tabl.